ArticleJournal of Alzheimer's disease : JAD2023

Advanced Alzheimer's Disease Patients Show Safe, Significant, and Persistent Benefit in 6-Month Bryostatin Trial.

Daniel L Alkon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.